| 000 | 03807naaaa2201069uu 4500 | ||
|---|---|---|---|
| 001 | https://directory.doabooks.org/handle/20.500.12854/57236 | ||
| 005 | 20220220034451.0 | ||
| 020 | _abooks978-3-03921-807-3 | ||
| 020 | _a9783039218073 | ||
| 020 | _a9783039218066 | ||
| 024 | 7 |
_a10.3390/books978-3-03921-807-3 _cdoi |
|
| 041 | 0 | _aEnglish | |
| 042 | _adc | ||
| 100 | 1 |
_aSorrenti, Valeria _4auth |
|
| 245 | 1 | 0 | _aProtective and Detrimental Role of Heme Oxygenase-1 |
| 260 |
_bMDPI - Multidisciplinary Digital Publishing Institute _c2019 |
||
| 300 | _a1 electronic resource (220 p.) | ||
| 506 | 0 |
_aOpen Access _2star _fUnrestricted online access |
|
| 520 | _aThe book “Protective and Detrimental Role of Heme Oxygenase-1”, includes a selection of original research papers and reviews aimed at understanding the dual role (protective and detrimental) of HO-1 and the involved signaling pathways. Original research papers and reviews aimed at the identification of natural molecules or new synthetic compounds able to modulate HO-1 activity/expression help make HO-1 a potential therapeutic target for the amelioration of various diseases. | ||
| 540 |
_aCreative Commons _fhttps://creativecommons.org/licenses/by-nc-nd/4.0/ _2cc _4https://creativecommons.org/licenses/by-nc-nd/4.0/ |
||
| 546 | _aEnglish | ||
| 653 | _acoronary artery disease | ||
| 653 | _an/a | ||
| 653 | _aglucocorticoid receptor | ||
| 653 | _aantigen presentation | ||
| 653 | _aanalgesia | ||
| 653 | _achemotherapy | ||
| 653 | _alocus coeruleus | ||
| 653 | _aSirtuin 1 | ||
| 653 | _athiol groups | ||
| 653 | _aHeme Oxygenase-1 | ||
| 653 | _aBetula etnensis Raf. | ||
| 653 | _aheme oxygenase 1 | ||
| 653 | _atolerance | ||
| 653 | _aheme oxygenase | ||
| 653 | _aatherosclerosis | ||
| 653 | _anitric oxide | ||
| 653 | _acaloric restriction | ||
| 653 | _aliver | ||
| 653 | _acarbon monoxide | ||
| 653 | _aER stress | ||
| 653 | _aheme oxygenase-1 | ||
| 653 | _amineralocorticoid receptor | ||
| 653 | _aType 1 diabetes mellitus (T1D) | ||
| 653 | _aGamma-Glutamyl-Cysteine Ligase (GGCL) | ||
| 653 | _aangiotensin II | ||
| 653 | _abilirubin | ||
| 653 | _aHeme oxygenase-1 (HO-1) inducers | ||
| 653 | _aInducible nitric oxide synthase (iNOS) | ||
| 653 | _aHO-1 activity inhibitor | ||
| 653 | _aferroptosis | ||
| 653 | _aMyristica fragrans kernels | ||
| 653 | _aglutathione | ||
| 653 | _ahigh-pressure gas | ||
| 653 | _aapoptosis | ||
| 653 | _aHO-1 | ||
| 653 | _adiabetes mellitus | ||
| 653 | _aCaffeic acid phenethyl ester (CAPE) | ||
| 653 | _acarotid plaque | ||
| 653 | _aischemia–reperfusion injury | ||
| 653 | _aANTIGEN presenting cell | ||
| 653 | _aLPS | ||
| 653 | _aendoplasmic reticulum stress | ||
| 653 | _ahemoglobin | ||
| 653 | _aPancreatic oxidative damage | ||
| 653 | _aColon cancer | ||
| 653 | _ainflammation | ||
| 653 | _areactive oxygen species | ||
| 653 | _ainflammatory pain | ||
| 653 | _aparacetamol | ||
| 653 | _acardiomyopathy | ||
| 653 | _aheme oxigenase-1 | ||
| 653 | _aadipocytes | ||
| 653 | _asirtuin 1 | ||
| 653 | _aperipheral artery disease | ||
| 653 | _aPGC-1? | ||
| 653 | _aheme | ||
| 653 | _aReactive oxygen species (ROS) | ||
| 653 | _ametformin | ||
| 653 | _aGR | ||
| 653 | _aprostate cancer | ||
| 653 | _aNF-?B | ||
| 653 | _ahyperbilirubinemia | ||
| 653 | _airon | ||
| 653 | _aTet-ON system | ||
| 653 | _alung preservation | ||
| 653 | _aoxidative stress | ||
| 653 | _aGunn rats | ||
| 653 | _aDimethylarginine dimethylaminohydrolase-1 (DDAH-1) | ||
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://mdpi.com/books/pdfview/book/1790 _70 _zDOAB: download the publication |
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://directory.doabooks.org/handle/20.500.12854/57236 _70 _zDOAB: description of the publication |
| 999 |
_c63138 _d63138 |
||